Eli Lilly shares ... billion for diabetes drug Mounjaro and $1.9 billion for Zepbound. That is much higher than a year earlier but short of analysts’ projections of $4.4 billion for Mounjaro and $2.1 ...

The drugs are ... Ricks said. Lilly on Monday approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled by Zepbound and Mounjaro. The company also raised ...

Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the ...